| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614057 | Journal of Cardiac Failure | 2017 | 25 Pages |
Abstract
RDN was associated with reductions in NT-proBNP and 120-minute glucose tolerance test in HF patients 12 months after RDN treatment. There was no deterioration in other indices of cardiac and renal function in this small feasibility study.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ingrid MBBS, PhD, Edoardo MD, Uta C. MD, Bengt MD, PhD, Thomas H. MBBS, PhD, MPh, Sharad MD, Christopher MD, Thomas MD, Dagmara MD, PhD, Murray MBBS, PhD, Markus MD, Antony MBBS, Flavio MD, Mathias C. MD, Sidney A. MD, PhD, Pascalle MSc, Henry MBBS, PhD,